A Randomized, 5-Period, Crossover Study in Healthy Subjects to Assess the Bioequivalence of Atazanavir When Co-Administered With Cobicistat as a Fixed Dose Combination Relative to the Single Agents Following a Light Meal, the Relative Bioavailability of Atazanavir When Co-Administered With Cobicistat as a Fixed Dose Combination Relative to the Single Agents Under Fasted Conditions, and the Effect of Food on the Bioavailability of Atazanavir in the Fixed Dose Combination
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Atazanavir/cobicistat (Primary) ; Atazanavir; Cobicistat
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Acronyms AtazanavirBE
- Sponsors Bristol-Myers Squibb
- 01 Jun 2013 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 03 May 2013 New trial record